Authors: NBI Biosciences and Dhanvi Herbal Agrotech

The industry of plant-origin medicines is witnessing a growing demand, boosted by the ongoing Covid-19 pandemic, as preventative healthcare and medicinal nutrition has been highly emphasized. The global market for plant-origin medicines is expected to grow at a CAGR of 9% from 2021-2028, while having already grown at 9.0%+ in the last few years1. Asia Pacific has over 31% market share and is expected to continue to lead it2. India provides an opportunistic base to meet the growing demand due to its rich natural biodiversity with over 50,000 plant species and access to low-cost production…